پس از اینکه بیوتکنولوژی چشم انداز فروش را افزایش داد، سهام مدرنا جهش کرد

Moderna’s stock jumps after biotech raises sales outlook

The company lifted its revenue outlook for the year, saying it now expects revenue to grow as much as 25% in 2026.